The American Journal of Medicine
Volume 118, Issue 5 , Pages 521-528, May 2005

Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial

  • Steven R. Simon, MD, MPH

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
    • Corresponding Author InformationRequests for reprints should be addressed to Steven R. Simon, MD, MPH, Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Avenue, Sixth Floor, Boston, MA 02215.
  • ,
  • Sumit R. Majumdar, MD, MPH

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
    • Division of General Internal Medicine, University of Alberta, Edmonton, Alberta, Canada
  • ,
  • Lisa A. Prosser, PhD

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
  • ,
  • Susanne Salem-Schatz, ScD

      Affiliations

    • HealthCare Quality Initiatives, Newton, Massachusetts
  • ,
  • Cheryl Warner, MD

      Affiliations

    • Harvard Vanguard Medical Associates, Medford, Massachusetts.
  • ,
  • Ken Kleinman, ScD

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
  • ,
  • Irina Miroshnik, MS

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts
  • ,
  • Stephen B. Soumerai, ScD

      Affiliations

    • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts

Received 27 August 2004; accepted 19 December 2004.

Purpose

To compare group versus individual academic detailing to increase diuretic or β-blocker use in hypertension.

Methods

We conducted a cluster-randomized controlled trial in a large health maintenance organization. Subjects (N=9820) were patients with newly treated hypertension in the year preceding the intervention (N=3692), the 9 months following the intervention (N=3556), and the second year following intervention (N=2572). We randomly allocated 3 practice sites to group detailing (N=227 prescribers), 3 to individual detailing (N=235 prescribers), and 3 to usual care (N=319 prescribers). Individual detailing entailed a physician-educator meeting individually with clinicians to address barriers to prescribing guideline-recommended medications. The group detailing intervention incorporated the same social marketing principles in small groups of clinicians.

Results

In the first year following the intervention, the rates of diuretic or β-blocker use increased by 13.2% in the group detailing practices, 12.5% in the individual detailing practices, and 6.2% in the usual care practices. As compared with usual care practices, diuretic or β-blocker use was more likely in group detailing practices (adjusted odds ratio (OR), 1.40; 95% confidence interval (CI), 1.11 – 1.76) and individual detailing practices (adjusted OR, 1.30; 95% CI, 0.95 – 1.79). Neither intervention affected blood pressure control. Two years following this single-visit intervention, there was still a trend suggesting a persistent effect of individual (OR, 1.22; 95% CI, 0.92 – 1.62), but not group, detailing (OR, 1.06; 95% CI, 0.80 – 1.39), as compared with usual care.

Conclusion

Both group and individual academic detailing improved antihypertensive prescribing over and above usual care but may require reinforcement to sustain improvements.

Key words:  Hypertension , Academic detailing , Quality of care , Clinical practice guidelines

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding/Support: This work was supported by a cooperative agreement (U18 HS 12019) from the Agency for Healthcare Research and Quality. Dr. Majumdar is a Population Health Investigator of the Alberta Heritage Foundation for Medical Research and a New Investigator of the Canadian Institutes of Health Research. Drs. Simon and Soumerai are investigators in the HMO Research Network Center for Education and Research in Therapeutics funded by the Agency for Healthcare Research and Quality (U18HS010391).Role of the Sponsor: The funders had no role in the design of the study, analysis of the data, interpretation of the results, or the decision to publish.

PII: S0002-9343(05)00044-6

doi:10.1016/j.amjmed.2004.12.023

The American Journal of Medicine
Volume 118, Issue 5 , Pages 521-528, May 2005